Pages

Wednesday, February 2, 2022

US FDA News: FDA Approves First Generic of Restasis

The U.S. Food and Drug Administration today approved an application for the first generic of Restasis (cyclosporine ophthalmic emulsion) eye drops to increase tear production.
Read more: FDA Approves First Generic of Restasis